Major global pharmaceutical companies such as Eli Lilly and Novartis have increased their research and development spending, according to the Global Innovation Index 2024, a report by the World Intellectual Property Office (WIPO).
Informatie preluata din publicatia „Bursa” – citeste integral articolul – click aici
